Program - Society of Toxicology
Program - Society of Toxicology
Program - Society of Toxicology
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Society</strong> <strong>of</strong> <strong>Toxicology</strong> 2011<br />
SOT 2011 Award Recipients<br />
Achievement Award<br />
Arnold J. Lehman Award<br />
SPECIal Events<br />
Nathan<br />
Cherrington<br />
Nathan Cherrington, Ph.D.,<br />
Associate Pr<strong>of</strong>essor <strong>of</strong> Pharmacology<br />
and <strong>Toxicology</strong>, College <strong>of</strong> Pharmacy,<br />
and Associate Pr<strong>of</strong>essor, Community<br />
Environment and Policy Division, Mel<br />
& Enid Zuckerman College <strong>of</strong> Public<br />
Health, University <strong>of</strong> Arizona, is the<br />
recipient <strong>of</strong> the SOT 2011 Achievement<br />
Award for his significant early career<br />
contributions to toxicology.<br />
Dr. Cherrington’s research focuses<br />
primarily on the role <strong>of</strong> disease<br />
states such as non-alcoholic steatohepatitis in the interindividual<br />
variability in drug metabolism and disposition.<br />
He has also extended his interest to examine the critical<br />
role that transporters play in the blood-testis barrier.<br />
Dr. Cherrington’s acclaim as an expert in transporter<br />
research has resulted in his inclusion as a member <strong>of</strong> various<br />
NIH Study Sections (NIDDK, NCCAM, XNDA, HBPP).<br />
For his studies, he has garnered support from NIH (NIDDK,<br />
NIAID, NICHD, NIEHS) and the Arizona State Disease<br />
Control Commission, as well as industrial support from<br />
AstraZeneca. The value <strong>of</strong> his research studies are further<br />
demonstrated in the competitive awards that his students<br />
have received via pre-doctoral NIH Awards and in student<br />
poster sessions at regional and national SOT meetings,<br />
including both Mechanisms and Drug Discovery <strong>Toxicology</strong><br />
Specialty Sections.<br />
Dr. Cherrington is an active member <strong>of</strong> SOT, serving on<br />
the Committee on Diversity Initiatives as well as having<br />
Regional Chapter assignments. He also serves on the<br />
Editorial Boards <strong>of</strong> Toxicological Sciences and other<br />
prominent journals in the field. He is an outstanding teacher<br />
and a prodigious author with numerous articles and a book<br />
chapter to his credit.<br />
Dr. Cherrington earned his B.S. from Brigham Young<br />
University (1993), a Ph.D. in <strong>Toxicology</strong> from North<br />
Carolina State University (1997) with Ernst Hodgson,<br />
and completed a successful postdoctoral fellowship at<br />
the University <strong>of</strong> Kansas Medical Center (2002) with<br />
Curtis Klaassen. He was recruited to the University<br />
<strong>of</strong> Arizona as an Assistant Pr<strong>of</strong>essor in 2002 where,<br />
in addition to his current responsibilities as Associate<br />
Pr<strong>of</strong>essor, he serves as the Director <strong>of</strong> the Pharmacology-<br />
<strong>Toxicology</strong> Graduate <strong>Program</strong> and as a Council member<br />
<strong>of</strong> the University’s Graduate College. For the significant<br />
contributions to toxicology that he has made in the<br />
early stages <strong>of</strong> his career, the <strong>Society</strong> <strong>of</strong> <strong>Toxicology</strong> is<br />
pleased to present the SOT 2011 Achievement Award to<br />
Dr. Nathan Cherrington.<br />
Bette Meek, Ph.D., is recognized as<br />
the 2011 Arnold J. Lehman Award<br />
recipient for her contributions to risk<br />
assessment and regulation <strong>of</strong> chemical<br />
agents.<br />
Dr. Meek is Associate Director,<br />
Chemical Risk Assessment,<br />
McLaughlin Centre for Population<br />
Health, University <strong>of</strong> Ottawa, having<br />
recently completed an Interchange<br />
Bette Meek<br />
from Health Canada, where she<br />
continues to develop opportunities for<br />
mutually beneficial interactions among the regulatory and<br />
academic communities and agencies such as the World<br />
Health Organization regarding health risk assessment, risk<br />
management, and risk communication.<br />
Widely recognized as a major driving force for the<br />
development and application <strong>of</strong> new technologies and<br />
approaches for improving the practice <strong>of</strong> human health risk<br />
assessment, Dr. Meek is especially distinguished as one <strong>of</strong><br />
the key individuals who have consistently led international<br />
efforts to move human health risk assessment forward<br />
scientifically. A prime example <strong>of</strong> her leadership has been<br />
her role in fostering the use <strong>of</strong> science-based methods<br />
including weight <strong>of</strong> evidence frameworks for incorporation<br />
<strong>of</strong> mode <strong>of</strong> action information and pharmacokinetic data and<br />
physiologically based pharmacokinetic (PBPK) modeling<br />
for determining the relationship between external exposure<br />
and internal (target tissue) exposure.<br />
A tireless, motivated, and committed contributor and<br />
leader, Dr. Meek has clearly demonstrated sustained and<br />
outstanding contributions to the knowledge and practice <strong>of</strong><br />
hazard characterization, dose response assessment, exposure<br />
assessment and risk characterization. Her efforts have led to<br />
major progress in the use <strong>of</strong> new methodologies in the health<br />
assessments conducted by Health Canada, and, through her<br />
work for national and international agencies, around the<br />
world. Among other attributes Bette is articulate, erudite,<br />
humorous, forward thinking, tenacious, and steely, making<br />
her a savvy opponent in any argument using well thought<br />
out, logical, and consistent thinking with the latest science<br />
or the appropriate application <strong>of</strong> the newer methods.<br />
Dr. Meek has moved the field <strong>of</strong> regulatory toxicology and<br />
risk assessment significantly forward though innovative<br />
thinking and principled risk assessment practice. In<br />
recognition <strong>of</strong> her achievements, the SOT Awards Committee<br />
is pleased to announce Dr. Bette Meek as the recipient <strong>of</strong> the<br />
2011 Arnold J. Lehman Award.<br />
up-to-date information at www.toxicology.org<br />
63